Segnalazioni da APRE a seguire delle informazioni nell'ambito HEALTH

La Call 22 (https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-22) è una call riservata alla massimizzazione dell'impatto degli obiettivi e delle priorità scientifiche di IMI2.

La Call 23 (https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-23) riguarda i seguenti topics:

• Topic 1: Returning clinical trial data to study participants within a GDPR compliant and approved ethical framework
• Topic 2: Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance
  This topic is part of IMI’s Antimicrobial Resistance (AMR) Accelerator programme.
• Topic 3: A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases
• Topic 4: Optimal treatment for patients with solid tumours in Europe through artificial intelligence
• Topic 5 Shortening the path to rare disease diagnosis by using new born genetic screening and digital technologies
• Topic 6: Behavioural model of factors affecting patient adherence

Per entrambe le calls la scadenza è il 29 settembre.